In the first quarter of 2016, there were 1,011 new deals in the pharmaceutical industry, slightly fewer than the previous quarter but more than the same quarter the year before. The article discusses the most valuable deals made during this time, as well as deals from major players in the industry. It also covers important updates on milestone, options, and terminated deals, and gives a preview of what to expect in the next quarter.